GBM

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

WBSI Guided Personalized Delivery of TTFields

Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma

LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients

Surgery and Laser Interstitial Thermal Therapy for Bilateral Glioblastomas

Surgical Nivolumab And Ipilimumab For Recurrent GBM

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

Imaging Acetadote Metabolism in Glioblastoma

Niraparib/TTFields in GBM

Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.

Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma

Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

Infigratinib in Recurrent High-Grade Glioma Patients